Damon Runyon identifies today’s most brilliant early career scientists and funds their innovative cancer research.

Andrew T. Chan, MD, MPH
Dr. Chan is developing molecular “smart” probes and novel imaging techniques for earlier and improved detection of colorectal cancer. He will soon be testing this promising technology in clinical trials. This work has the potential to accelerate the discovery and development process for therapeutic and chemopreventative agents in colorectal cancer.
Project Title: "Molecular imaging of colorectal neoplasia"
Institution: Massachusetts General Hospital
Sponsor(s) / Mentor(s): Charles Fuchs, MD, MPH & Ralph Weissleder, MD, PhD
Cancer Type: Colorectal
Research Area: Imaging



